Just starting a fun thread! (posted also in the RAD thread).
I was thinking about investing in a promising Paul Hopper Biotech.
RAD and CHM have similar market caps, are in the cancer space, with multiple IP opportunities, similar cash burn with similar cash on hand and at a similar age in its corporate evolution. If you had to choose only one investment, which would it be and why?
Just starting a fun thread! (posted also in the RAD thread).I...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.001(4.35%) |
Mkt cap ! $20.55M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.4¢ | 2.2¢ | $39.89K | 1.721M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1248246 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 9533 | 2 |
View Market Depth
| Last trade - 16.10pm 22/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.4¢ |
Change
0.001 ( 4.35 %) |
||||
| Open | High | Low | Volume | ||
| 2.3¢ | 2.4¢ | 2.2¢ | 627560 | ||
| Last updated 13.47pm 22/05/2024 ? | |||||
| CHM (ASX) Chart |